Wheelsbridge AB develops, manufactures and brings to market technologies for quantification of skin erythema and other skin parameters.

The Tissue Viability Imager TiVi700 2.0 (TiVi) is based on the principles of polarization spectroscopy imaging and facilitates objective assessment of the safety and efficacy of novel skin care products in the development and validation phase.

In addition to creating maps of skin microcirculation TiVi is now also equipped with software extensions for assessment of:

• Blackhead and whitehead spots (comedones).
• Colour changes within selected skin sites over time.

Quantitative assessment of comedones.

Upper left: baseline photo | Lower left: endpoint

Upper right: number of spots versus photo number | Lower right: number of spots versus spot size

www.wheelsbridge.com | Corporate and testing sheet: https://skinobs.com/instrumentation.php?id=109

Read the entire ZOOM#23 here

CONTACT

https://wheelsbridge.se/

Phone: +46 708-765-190

E-mail: info@wheelsbridge.se